• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部脑代谢减退与局部淀粉样斑块负荷无关。

Regional brain hypometabolism is unrelated to regional amyloid plaque burden.

作者信息

Altmann Andre, Ng Bernard, Landau Susan M, Jagust William J, Greicius Michael D

机构信息

1 FIND Lab, Department of Neurology and Neurological Sciences, Stanford University, Stanford California, USA.

2 Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California, USA.

出版信息

Brain. 2015 Dec;138(Pt 12):3734-46. doi: 10.1093/brain/awv278. Epub 2015 Sep 29.

DOI:10.1093/brain/awv278
PMID:26419799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4806718/
Abstract

In its original form, the amyloid cascade hypothesis of Alzheimer's disease holds that fibrillar deposits of amyloid are an early, driving force in pathological events leading ultimately to neuronal death. Early clinicopathological investigations highlighted a number of inconsistencies leading to an updated hypothesis in which amyloid plaques give way to amyloid oligomers as the driving force in pathogenesis. Rather than focusing on the inconsistencies, amyloid imaging studies have tended to highlight the overlap between regions that show early amyloid plaque signal on positron emission tomography and that also happen to be affected early in Alzheimer's disease. Recent imaging studies investigating the regional dependency between metabolism and amyloid plaque deposition have arrived at conflicting results, with some showing regional associations and other not. We extracted multimodal neuroimaging data from the Alzheimer's disease neuroimaging database for 227 healthy controls and 434 subjects with mild cognitive impairment. We analysed regional patterns of amyloid deposition, regional glucose metabolism and regional atrophy using florbetapir ((18)F) positron emission tomography, (18)F-fluordeoxyglucose positron emission tomography and T1-weighted magnetic resonance imaging, respectively. Specifically, we derived grey matter density and standardized uptake value ratios for both positron emission tomography tracers in 404 functionally defined regions of interest. We examined the relation between regional glucose metabolism and amyloid plaques using linear models. For each region of interest, correcting for regional grey matter density, age, education and disease status, we tested the association of regional glucose metabolism with (i) cortex-wide florbetapir uptake; (ii) regional (i.e. in the same region of interest) florbetapir uptake; and (iii) regional florbetapir uptake while correcting in addition for cortex-wide florbetapir uptake. P-values for each setting were Bonferroni corrected for 404 tests. Regions showing significant hypometabolism with increasing cortex-wide amyloid burden were classic Alzheimer's disease-related regions: the medial and lateral parietal cortices. The associations between regional amyloid burden and regional metabolism were more heterogeneous: there were significant hypometabolic effects in posterior cingulate, precuneus, and parietal regions but also significant positive associations in bilateral hippocampus and entorhinal cortex. However, after correcting for global amyloid burden, few of the negative associations remained and the number of positive associations increased. Given the wide-spread distribution of amyloid plaques, if the canonical cascade hypothesis were true, we would expect wide-spread, cortical hypometabolism. Instead, cortical hypometabolism appears to be linked to global amyloid burden. Thus we conclude that regional fibrillar amyloid deposition has little to no association with regional hypometabolism.

摘要

在其最初形式中,阿尔茨海默病的淀粉样蛋白级联假说认为,淀粉样蛋白的纤维状沉积物是导致最终神经元死亡的病理事件中的早期驱动力。早期临床病理研究突出了一些不一致之处,从而产生了一个更新的假说,即淀粉样斑块让位于淀粉样寡聚体成为发病机制中的驱动力。淀粉样蛋白成像研究没有关注这些不一致之处,而是倾向于强调在正电子发射断层扫描上显示早期淀粉样斑块信号且恰好也在阿尔茨海默病早期受到影响的区域之间的重叠。最近研究代谢与淀粉样斑块沉积之间区域依赖性的成像研究得出了相互矛盾的结果,一些研究显示出区域关联,而另一些则没有。我们从阿尔茨海默病神经成像数据库中提取了227名健康对照者和434名轻度认知障碍受试者的多模态神经成像数据。我们分别使用氟代贝他吡((18)F)正电子发射断层扫描、(18)F - 氟脱氧葡萄糖正电子发射断层扫描和T1加权磁共振成像分析了淀粉样蛋白沉积的区域模式、区域葡萄糖代谢和区域萎缩情况。具体而言,我们在404个功能定义的感兴趣区域中得出了两种正电子发射断层扫描示踪剂的灰质密度和标准化摄取值比率。我们使用线性模型研究了区域葡萄糖代谢与淀粉样斑块之间的关系。对于每个感兴趣区域,在校正区域灰质密度、年龄、教育程度和疾病状态后,我们测试了区域葡萄糖代谢与以下各项的关联:(i) 全皮质氟代贝他吡摄取;(ii) 区域(即同一感兴趣区域内)氟代贝他吡摄取;以及(iii) 在校正全皮质氟代贝他吡摄取的同时进行区域氟代贝他吡摄取。每种情况下的P值都针对404次测试进行了Bonferroni校正。随着全皮质淀粉样蛋白负担增加而显示出显著代谢减低的区域是典型的阿尔茨海默病相关区域:内侧和外侧顶叶皮质。区域淀粉样蛋白负担与区域代谢之间的关联更为多样:在扣带回后部、楔前叶和顶叶区域存在显著的代谢减低效应,但在双侧海马体和内嗅皮质也存在显著的正相关。然而,在校正整体淀粉样蛋白负担后,几乎没有负相关关系留存,而正相关关系的数量增加了。鉴于淀粉样斑块分布广泛,如果经典的级联假说正确,我们会预期广泛的皮质代谢减低。相反,皮质代谢减低似乎与整体淀粉样蛋白负担相关。因此我们得出结论,区域纤维状淀粉样蛋白沉积与区域代谢减低几乎没有关联。

相似文献

1
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.局部脑代谢减退与局部淀粉样斑块负荷无关。
Brain. 2015 Dec;138(Pt 12):3734-46. doi: 10.1093/brain/awv278. Epub 2015 Sep 29.
2
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.阿尔茨海默病成像生物标志物的比较:使用[18F]氟比他哌正电子发射断层扫描进行淀粉样蛋白成像以及对内嗅皮质萎缩进行基于磁共振成像体素的分析。
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
3
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.脑血管阻力:对认知衰退、皮质萎缩及向痴呆进展的影响。
Brain. 2017 Jul 1;140(7):1987-2001. doi: 10.1093/brain/awx112.
4
Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.年龄、β-淀粉样蛋白沉积和葡萄糖代谢之间的动态关系与阿尔茨海默病的区域易损性相关。
Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108. Epub 2016 May 13.
5
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.tau 沉积与正常和早期有症状个体中淀粉样-β 积累率的关系。
Brain. 2017 May 1;140(5):1499-1512. doi: 10.1093/brain/awx046.
6
Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.早发性阿尔茨海默病中的淀粉样蛋白负担和代谢功能:顶叶受累。
Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113. Epub 2012 May 3.
7
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.
8
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
9
Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.双相(18)F-氟代硼吡咯(AV-45/Amyvid)PET在阿尔茨海默病和轻度认知障碍中同时检测灌注缺损和β-淀粉样蛋白沉积的成像特征
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1304-14. doi: 10.1007/s00259-016-3359-8. Epub 2016 Mar 22.
10
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.在可能的阿尔茨海默病的临床变异型中,淀粉样蛋白沉积和低代谢的模式存在差异。
Brain. 2013 Mar;136(Pt 3):844-58. doi: 10.1093/brain/aws327. Epub 2013 Jan 28.

引用本文的文献

1
Deuterium trafficking, mitochondrial dysfunction, copper homeostasis, and neurodegenerative disease.氘转运、线粒体功能障碍、铜稳态与神经退行性疾病。
Front Mol Biosci. 2025 Jul 22;12:1639327. doi: 10.3389/fmolb.2025.1639327. eCollection 2025.
2
Alpha-frequency stimulation strengthens coupling between temporal fluctuations in alpha oscillation power and default mode network connectivity.阿尔法频率刺激增强了阿尔法振荡功率的时间波动与默认模式网络连通性之间的耦合。
eNeuro. 2025 Mar 11;12(3). doi: 10.1523/ENEURO.0449-24.2025.
3
Macroscale Gradient Dysfunction in Alzheimer's Disease: Patterns With Cognition Terms and Gene Expression Profiles.

本文引用的文献

1
Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.使用¹¹C-匹兹堡化合物B正电子发射断层扫描(PET)和死后神经病理学评估淀粉样β蛋白的积累。
Curr Alzheimer Res. 2015;12(3):278-86. doi: 10.2174/1567205012666150302155930.
2
Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.50至89岁认知功能正常人群中脑β-淀粉样变性和神经退行性变的年龄特异性人群频率:一项横断面研究。
Lancet Neurol. 2014 Oct;13(10):997-1005. doi: 10.1016/S1474-4422(14)70194-2. Epub 2014 Sep 4.
3
Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease.
阿尔茨海默病的宏观梯度功能障碍:与认知术语和基因表达谱相关的模式。
Hum Brain Mapp. 2024 Oct 15;45(15):e70046. doi: 10.1002/hbm.70046.
4
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review.探索阿尔茨海默病中线粒体功能障碍的机制和治疗方法:一篇教育性文献综述。
Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10.
5
Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APP knock-in mouse model of Alzheimer's disease.线粒体对营养物质的反应失调是阿尔茨海默病 APP 基因敲入小鼠模型皮质的一个先兆事件。
Alzheimers Dement. 2024 Oct;20(10):6844-6859. doi: 10.1002/alz.14144. Epub 2024 Aug 22.
6
Aging Brain from a Lifespan Perspective.从寿命视角看大脑衰老。
Curr Top Behav Neurosci. 2024;68:349-370. doi: 10.1007/7854_2024_476.
7
Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy.阿尔茨海默病:对病理学、分子机制及治疗的见解
Protein Cell. 2025 Feb 1;16(2):83-120. doi: 10.1093/procel/pwae026.
8
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer's Disease Therapy.胰高血糖素样肽-1类似物、钠-葡萄糖协同转运蛋白2抑制剂和二肽基肽酶-4抑制剂:阿尔茨海默病治疗的三联希望
Biomedicines. 2023 Nov 12;11(11):3035. doi: 10.3390/biomedicines11113035.
9
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.甘草查尔酮 A:治疗阿尔茨海默病的一种潜在多靶药物。
Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177.
10
Integrating mind and body: Investigating differential activation of nodes of the default mode network.身心整合:探究默认模式网络节点的差异激活。
Restor Neurol Neurosci. 2023;41(3-4):115-127. doi: 10.3233/RNN-231334.
内在网络紊乱将淀粉样蛋白-β病理与前驱性阿尔茨海默病的认知障碍联系起来。
Cereb Cortex. 2015 Dec;25(12):4678-88. doi: 10.1093/cercor/bhu151. Epub 2014 Jul 4.
4
In vivo tau imaging: obstacles and progress.体内 tau 成像:障碍与进展。
Alzheimers Dement. 2014 Jun;10(3 Suppl):S254-64. doi: 10.1016/j.jalz.2014.04.013.
5
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.在三种存在潜在阿尔茨海默病病理学特征的情况下,对氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)和匹兹堡化合物B正电子发射断层扫描(PiB-PET)进行并行独立成分分析。
Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.
6
Association of hypometabolism and amyloid levels in aging, normal subjects.衰老正常人群中代谢低下与淀粉样蛋白水平的关系。
Neurology. 2014 Jun 3;82(22):1959-67. doi: 10.1212/WNL.0000000000000467. Epub 2014 May 2.
7
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.基于PET模板法与基于MRI法在体内对氟代硼吡咯(AV-45)摄取进行皮质定量分析的比较。
Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8. Epub 2013 Dec 19.
8
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.认知正常个体、高危人群和临床前阿尔茨海默病的淀粉样蛋白成像。
Neuroimage Clin. 2013 Mar 5;2:356-65. doi: 10.1016/j.nicl.2013.02.006. eCollection 2013.
9
In vivo characterization of the early states of the amyloid-beta network.体内鉴定淀粉样β网络的早期状态。
Brain. 2013 Jul;136(Pt 7):2239-52. doi: 10.1093/brain/awt146.
10
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.在可能的阿尔茨海默病的临床变异型中,淀粉样蛋白沉积和低代谢的模式存在差异。
Brain. 2013 Mar;136(Pt 3):844-58. doi: 10.1093/brain/aws327. Epub 2013 Jan 28.